Literature DB >> 12519891

Genetic mapping studies of familial juvenile hyperuricemic nephropathy on chromosome 16p11-p13.

Joanna M Stacey1, Jeremy J O Turner, Brian Harding, M Andrew Nesbit, Peter Kotanko, Karl Lhotta, Juan G Puig, Rosa J Torres, Rajesh V Thakker.   

Abstract

Familial juvenile hyperuricemic nephropathy (FJHN), which is inherited as an autosomal dominant disorder, is characterized by hyperuricemia, a low fractional renal excretion of urate, and chronic renal failure that is associated with interstitial fibrosis. Studies in 4 families (3 European and 1 Japanese) have mapped the gene causing autosomal dominant FJHN to chromosome 16p11-p13. To refine this location we have pursued linkage studies in 7 European families with autosomal dominant FJHN and used 11 chromosome 16p11-p13 polymorphic loci whose order has been established as 16pter-D16S3069-D16S3060-D16S3041-D16S3036-D16S3046-[D16S403,D16S417]-D16S420-D16S3113-D16S401-D16S3133-16cen. Cosegregation between these polymorphic loci and FJHN was observed in 5 of the families, and linkage was established between FJHN and 6 loci (peak LOD score, 5.32 with D16S417, at 0% recombination), with the most likely location of FJHN being within a 22-centimorgan interval flanked centromerically by D16S401 and telomerically by D16S3069. Furthermore, FJHN in 2 families was found not to be linked to chromosome 16p11-p13, thereby demonstrating genetic heterogeneity. Thus, 5 additional families with FJHN showing linkage to chromosome 16p11-p13 loci have been identified, and genetic heterogeneity has been demonstrated in more than 25% of FJHN families. These results will facilitate the characterization of this gene regulating urate metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519891     DOI: 10.1210/jc.2002-021268

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Mutation analysis of the Uromodulin gene in 96 individuals with urinary tract anomalies (CAKUT).

Authors:  Matthias T F Wolf; Bethan E Hoskins; Bodo B Beck; Bernd Hoppe; Velibor Tasic; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2008-10-10       Impact factor: 3.714

2.  Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.

Authors:  Sian E Piret; Patrick Danoy; Karin Dahan; Anita A C Reed; Karena Pryce; William Wong; Rosa J Torres; Juan G Puig; Thomas Müller; Peter Kotanko; Karl Lhotta; Olivier Devuyst; Matthew A Brown; Rajesh V Thakker
Journal:  Hum Genet       Date:  2010-10-26       Impact factor: 4.132

Review 3.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

4.  A case of familial juvenile hyperuricemic nephropathy with novel uromodulin gene mutation, a novel heterozygous missense mutation in Korea.

Authors:  Dong Hun Lee; Jin Kyung Kim; Sook Eui Oh; Jung Woo Noh; Young-Ki Lee
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

5.  Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.

Authors:  Karl Lhotta; Sian E Piret; Reinhard Kramar; Rajesh V Thakker; Gere Sunder-Plassmann; Peter Kotanko
Journal:  Nephron Extra       Date:  2012-06-01

6.  First Report of Familial Juvenile Hyperuricemic Nephropathy (FJHN) in Iran Caused By a Novel De Novo Mutation (E197X) in UMOD.

Authors:  Tahereh Malakoutian; Atefeh Amouzegar; Farzaneh Vali; Mojgan Asgari; Babak Behnam
Journal:  J Mol Genet Med       Date:  2016-05-29

7.  Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.

Authors:  Siân E Williams; Anita A C Reed; Juris Galvanovskis; Corinne Antignac; Tim Goodship; Fiona E Karet; Peter Kotanko; Karl Lhotta; Vincent Morinière; Paul Williams; William Wong; Patrik Rorsman; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2009-05-22       Impact factor: 6.150

8.  Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Silvia Reichart; Charlotte Philpott; Kate E Lines; Caroline M Gorvin; Karl Lhotta; Jenny C Taylor; Rajesh V Thakker
Journal:  Am J Med Genet A       Date:  2020-08-09       Impact factor: 2.578

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.